Coles peanut butter recall after cancer-causing toxin found
Coles has issued a major product recall after two of its home-brand peanut butter products were found to be contaminated with a toxin.
Coles Smooth Peanut Butter 1kg and Coles Crunchy Peanut Butter 1kg jars sold between the of May and June this year have been recalled nationally due to aflatoxin contamination.
Aflatoxin is a biotoxin that can cause injury or illness if consumed.
It comes from a family of toxins that is found on crops including corn and peanuts.
Exposure to aflatoxins has been associated with an increased risk of liver cancer.
Coles is recalling two peanut butter products after a potentially toxic contamination.
Food Standards has warned consumers not to eat the product and to return it to their place of purchase.
Customers should beware of any product with the best before date of 5 February 2027.
Anyone concerned about their health should seek medical advice.
Anyone who bought the peanut butter products can return the jars to any Coles supermarket for a full refund, online customers can contact Coles Online Customer Care.
Coles apologised to customers 'for any inconvenience'.
Read related topics: Coles
Brendan Kearns
Cadet Journalist
Brendan Kearns is a cadet journalist with News Corp Australia. He has written for The Australian, the Herald Sun, the Geelong Advertiser, CHOICE, Cosmos, and The Citizen. He won Democracy's Watchdogs' Student Award for Investigative Journalism 2024 and hosted the third season of award-winning podcast Uncurated. He studied as Master of Journalism at The University of Melbourne, before that he worked as a video producer and disability worker.
@brendandkearns
Brendan Kearns
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

ABC News
33 minutes ago
- ABC News
Australia's lung cancer screening program has started — should eligibility be expanded?
Nicole Ives was about to leave hospital after surgery to remove her infected appendix when medics made a chance discovery that would save her life. An abdominal scan in October 2021 picked up a lump in her right lung. "And there was a high probability that it was lung cancer," Ms Ives said. The timing was both devastating and lucky. Just seven months earlier, the Queenslander had lost her much-loved husband Michael to "horrific" oesophageal cancer, leaving their three teenage children bereft. Another cancer diagnosis was too much. While she was exposed to a lot of cigarette smoke in the 1970s and '80s, as an avowed non-smoker herself, the type of cancer was also a shock. "Because they [health authorities] did such a great job educating us about lung cancer and smoking, for someone like me, who never smoked, I probably wouldn't have thought myself vulnerable in any way," the 57-year-old said. But the early diagnosis was also a blessing. Her medical team monitored the mass until changes were spotted on scans last year, prompting her surgeon to remove a wedge of lung containing the tumour. "It just blows my mind that I had that surgery and with clear margins, and that I haven't had to go through chemotherapy or anything else," the primary school teacher said. Ms Ives had no symptoms when the scan first detected her early-stage cancer. "I had no idea that it was there," she said. Thoracic physician Dr Kwun Fong said lung cancer is the number one cause of cancer deaths in Australia and worldwide. Around 9,000 Australians die from the disease each year. "The reason why it's got such a poor outcome is because when we detect it, usually it's at a very late stage where cure is no longer possible and that's because the lungs are an internal organ," Dr Fong said. "By the time we get symptoms, the cancer might be well advanced." The lung cancer researcher said smoking is the biggest risk factor for the disease, but other contributors include air pollution, diesel fumes, asbestos exposure and a genetic predisposition. "In women who've developed lung cancer, about a third of women do not have a history of smoking," Dr Fong said. One in 10 men diagnosed with lung cancer are non-smokers, according to the Lung Foundation Australia. For the past decade, the specialist, based at The Prince Charles Hospital in Brisbane, has been conducting trials to assess the value of screening certain groups of people for lung cancer. The latest phase will include 3,000 participants from across Australia in three different arms: never or light smokers, Aboriginal and Torres Strait Islander people, and current or former smokers. Those who qualify for the trial will have a low-dose chest CT scan to check for early signs of lung cancer. Senior health worker Mark Dorante encouraged eligible Indigenous Australians to participate. Dr Fong said the research aims to discover evidence that can help "tweak and improve" the newly launched National Lung Cancer Screening Program for heavy current or former smokers aged between 50 and 70 years old. It's estimated the targeted program will save 12,000 lives over the next decade. "We're very fortunate, we're one of the few countries where this national program will be rolled out," he said. But not everyone is eligible, and Dr Fong said his latest trial aims to "advance the knowledge by finding out who else will benefit [from checks]". Firefighters are one group eager for screening due to the risks of cancer-causing smoke. General manager of the Rural Fire Brigades Association Queensland, Justin Choveaux, said firies can be exposed "day in and day out" for months during the nation's long fire seasons. "My suggestion and my hope would be that all firefighters, whether you be full-time, part-time or volunteer, would be able to access free screening," Mr Choveaux said. The downsides of screening programs can include false positives, exposure to radiation from scans, and the detection of conditions that might never cause harm. Dr Fong said his screening trial is expected to take up to three years to complete. "[We] have to make sure that the benefits outweigh the harms and it's affordable and can be feasible and practical in our health care system," he said. A spokesperson for the federal Department of Health said the National Lung Cancer Screening Program (NLCSP) is "underpinned by strong clinical evidence". "The NLCSP will undergo a comprehensive evaluation after two years to ensure that it remains responsive and evidence-based, which may include changes to the eligibility criteria," the spokesperson said. "Individuals who believe they may be at risk of lung cancer or have concerns about their lung health, should not wait for screening and are strongly encouraged to consult their healthcare provider." These days Nicole Ives is focused on her "strong" and "pragmatic" children, her kayaking trips and lifelong love of art. She's "overwhelmed" by the standard of health care she received and doesn't dwell on her lung cancer, a life perspective she shared with Michael. Details of the Australian Lung Screen Trial can be found here.

ABC News
an hour ago
- ABC News
'Boeing 737' full of Aussies dying of drug overdoses every month, researchers say
There have been more than 2,000 fatal overdoses in Australia for the tenth year in a row, according to a new analysis by the Penington Institute. The non-profit drug research and advocacy group's CEO, John Ryan, said an early preview of its annual overdose report, due later this year, revealed there was 2,272 fatal overdoses in 2023, equating to an average of 189 per month. "We're losing the equivalent of a Boeing 737 full of Australians every month," he said. "The overdose toll has long exceeded the road toll … it's a huge problem that gets very little attention compared to other causes of death," he said. The majority of deaths (77.8 per cent) were unintentional, the data showed. The report broke down the most recent Australian Bureau of Statistics data on drug induced deaths, which is from 2023. The analysis showed overdose deaths were down by about 6 per cent on the previous year, based on preliminary data which would be subject to updates over the coming months. Mr Ryan said that drop was way too small. "Even if the numbers dropped by 20 or 30 or 40 per cent, it's still too high … it's outrageous that we've got such a huge number of people that are dying." The Penington analysis showed the rate of drug-induced deaths among Aboriginal and Torres Strait Islander peoples remained significantly higher (21.3 per 100,000 people) compared to non-Indigenous people (5.7 per 100,000). Opioids such as heroin and pharmaceutical opioids remained the most common drug type involved in unintentional deaths, contributing to almost half of all deaths (43.9 per cent), according to the report. Stimulant drugs such as methamphetamine increased by 2 per cent, overtaking benzodiazepines as the second most common drug type involved in unintentional fatal overdoses. Amanda Roxburgh, a senior research fellow and clinical psychologist at the Burnet Institute, said Australia was a major destination for methamphetamine. "It's relatively cheap to buy and it's really readily available," she said. Dr Roxburgh, who was not involved in the Penington Institute report, said while there have been increasing use and harms related to cocaine, that was limited because cocaine was much more expensive. She said crystal methamphetamine was now the predominant stimulant drug used in Australia, and it was often highly potent. "We're not only seeing increases in deaths related to methamphetamine but we're also seeing increases in the hospitalisations," she said. Dr Roxburgh said drug-related deaths involving stimulants, which increase heart rate and blood pressure, often involved cardiac events such as heart failure, blockages to major arteries and heart attacks. Opioid overdoses usually involved depression of the respiratory system, which sees a lack of oxygen to the brain. Dr Roxburgh said overdoses often involved both kinds of drugs. Most drug overdoses involved more than one drug. Mr Ryan said it was not just illegal drugs involved in overdoses, but prescription opioids and benzodiazapines as well. He said that was something he had personal experience of. "The daughter of a friend of mine who went through a messy divorce ended up on benzodiazepines to manage the stress and anxiety. "One night she drank a bit more red wine than usual, fell asleep on the couch and was found dead the next day. Mr Ryan said not only were most drug overdoses accidental, but they also extended to a demographic beyond injecting drug users and those using illicit street drugs. "Many of these deaths are occurring in private homes and often it's lounge rooms in suburbia and regional and rural towns," he said. Suzanne Nielsen, from the Monash Addiction Research Centre, said counterfeit prescription drugs were an issue increasing the risk of overdoses. "We know that these fake or falsified pharmaceuticals look very similar to the real thing. Even pharmacists wouldn't necessarily be able to pick them apart immediately," she said. Professor Nielsen said such drugs were available online and made in illegal labs. "We've got very used to buying things online, but when it comes to pharmaceuticals, it's really not safe," she said. Professor Nielsen said many illegal drugs, including fake pharmaceuticals, could contain powerful synthetic opioids including fentanyl and nitazenes, some of which were "100 times more potent than heroin". Do you have a story to share? Email Professor Nielsen said nitazenes have also turned up in drugs such as cocaine, ketamine and MDMA, which can leave people particularly vulnerable to opioid overdose because their presence was unexpected. In Melbourne last year, four men died after taking drugs laced with nitazenes. The Penington Institute is a not-for-profit drug policy research group with a focus on reducing overdose deaths and drug related harm, and advocates for decriminalisation and regulation of cannabis in Australia. Mr Ryan said overdose deaths were preventable and the high numbers of these deaths each year highlighted the need for a national overdose strategy that focused more on harm reduction and less on policing. He said only a small amount of funding went to harm reduction such as overdose education, opioid overdose withdrawal drug naloxone, drug testing and safe injecting facilities, and with a much bigger share went to law enforcement. He called on the government to implement a community education campaign, including to help people understand the signs of overdose like unusual snoring or gurgling sounds. "That … is often actually the sign of an overdose and there's many deaths that result from people not knowing the signs of an overdose, let alone knowing how to response to that." In a statement a spokesperson for the federal Department of Health said the National Drug Strategy provided a "commitment to harm minimisation through a balanced adoption of evidence based demand, supply and harm reduction strategies". The spokesperson said the government has subsidised opioid dependence treatment medicines through the Pharmaceutical Benefits Scheme and was investing $377 million over four years for those treatments to be delivered via community pharmacies. The statement also highlighted the government's ongoing commitment the Take Home Naloxone program which gives Australians free access to the drug which temporarily reverses the effects of an opioid overdose.

The Australian
7 hours ago
- The Australian
Coles peanut butter recall after cancer-causing toxin found
Coles has issued a major product recall after two of its home-brand peanut butter products were found to be contaminated with a toxin. Coles Smooth Peanut Butter 1kg and Coles Crunchy Peanut Butter 1kg jars sold between the of May and June this year have been recalled nationally due to aflatoxin contamination. Aflatoxin is a biotoxin that can cause injury or illness if consumed. It comes from a family of toxins that is found on crops including corn and peanuts. Exposure to aflatoxins has been associated with an increased risk of liver cancer. Coles is recalling two peanut butter products after a potentially toxic contamination. Food Standards has warned consumers not to eat the product and to return it to their place of purchase. Customers should beware of any product with the best before date of 5 February 2027. Anyone concerned about their health should seek medical advice. Anyone who bought the peanut butter products can return the jars to any Coles supermarket for a full refund, online customers can contact Coles Online Customer Care. Coles apologised to customers 'for any inconvenience'. Read related topics: Coles Brendan Kearns Cadet Journalist Brendan Kearns is a cadet journalist with News Corp Australia. He has written for The Australian, the Herald Sun, the Geelong Advertiser, CHOICE, Cosmos, and The Citizen. He won Democracy's Watchdogs' Student Award for Investigative Journalism 2024 and hosted the third season of award-winning podcast Uncurated. He studied as Master of Journalism at The University of Melbourne, before that he worked as a video producer and disability worker. @brendandkearns Brendan Kearns